NRP1 and central nervous system cancer: Specifically, EVs decorated with RGERPPR, a peptide ligand for neuropilin-1 which is highly expressed on glioma cells but not other neuronal cells (130, 131), were able to target glioma cells in an orthotopic mouse model (132).